Showing 6381-6390 of 19367 results for "".
The Cost of Progress: Examining Barriers to ATTR-CM Care
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/the-cost-of-progress-examining-barriers-to-attr-cm-care/39315/With three landmark therapies reshaping transthyretin amyloid cardiomyopathy (ATTR-CM) care, patient outcomes have been significantly improved. However, the recent advancements are accompanied by equity and accessibility challenges, particularly when it comes to navigating insurance barriers. Dr. MiNavigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
https://reachmd.com/programs/clinicians-roundtable/navigating-pediatric-obesity-tools-and-strategies-for-success-in-primary-care/37868/Discussing weight with pediatric patients and families is a nuanced challenge shaped by stigma, culture, and access—but it’s also a vital opportunity for early intervention. Dr. Jaime Moore shares how to build confidence, counter bias, and leverage practical tools and partnerships that supporBeyond Plaques: Treatment Challenges and Strategies in Palmoplantar Psoriasis
https://reachmd.com/programs/frontlines-psoriasis/beyond-plaques-treatment-challenges-and-strategies-in-palmoplantar-psoriasis/32442/Palmoplantar psoriasis is a high-impact, functionally burdensome condition that often resists conventional therapies. Characterized by painful fissures, thickened plaques, and distinct immune drivers, it requires a treatment approach beyond what's used for classic plaque psoriasis. To learn more, DrJournal Club: Combination Therapy With Dupilumab and Upadacitinib
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combination-therapy-with-dupilumab-and-upadacitinib/32408/Neal Bhatia, MD, FAAD, and Ted Lain, MD, MBA, FAAD, discuss the International Journal of Dermatology article “Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis,” and their own experiences with similar treatment strategies.From Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
https://reachmd.com/programs/project-oncology/from-policy-to-practice-what-the-who-lung-health-resolution-means-for-lung-cancer-care/36561/The World Health Organization's new Integrated Lung Health Resolution is the first to explicitly include lung cancer within a global lung health framework. In this AudioAbstract, ReachMD's Ryan Quigley explains what this means for screening, early diagnosis, care pathways, and equitable access to trUnlocking Tumor Complexity: Single-Cell RNA Sequencing in Lung Cancer
https://reachmd.com/programs/project-oncology/unlocking-tumor-complexity-single-cell-rna-sequencing-in-lung-cancer/36553/Single-cell RNA sequencing is transforming our understanding of tumor heterogeneity in primary lung cancers by offering insights far beyond traditional bulk sequencing. In this program, Dr. Paola Marignani explores how advanced machine learning enables faster, more precise profiling of genetic diverDiagnosing and Staging Non-Small Cell Lung Cancer: Key Updates and Evolving Strategies
https://reachmd.com/programs/deep-breaths-updates-chest/diagnosing-and-staging-non-small-cell-lung-cancer-key-updates-and-evolving-strategies/35979/For patients with non-small cell lung cancer, staging accuracy is critical in guiding treatment decisions that can significantly affect outcomes. In this expert-led discussion, Dr. Gerard Silvestri sits down with Drs. Anne Gonzalez and Jeffrey Velotta break down what clinicians need to know, includiOptimizing NSCLC Care: Advances in Lung Biopsy and Biomarker Testing
https://reachmd.com/programs/deep-breaths-updates-chest/program-name/35980/Cutting-edge biopsy methods and streamlined biomarker testing are transforming early-stage non-small cell lung cancer (NSCLC) care. Hear from Drs. Gerard Silvestri, Fabien Maldonado, and Adam Fox as they discuss the evolution of bronchoscopic techniques, insights from landmark trials, and the role oDecoding COPD: Precision Medicine Approaches for Complex Patient Profiles
https://reachmd.com/programs/frontlines-copd/decoding-copd-precision-medicine-approaches-for-complex-patient-profiles/35540/Chronic obstructive pulmonary disease (COPD) remains difficult to treat due to its varied disease stages, genetic risks, and diverse clinical presentations. And since traditional approaches struggle to slow progression, there's a growing need to look beyond a one-size-fits-all model. That’s why Dr.Building a Multidisciplinary Care Team for Sickle Cell Disease Patients
https://reachmd.com/programs/project-oncology/building-a-multidisciplinary-care-team-for-sickle-cell-disease-patients/36450/Sickle cell disease extends far beyond hematology, impacting multiple organ systems and requiring truly comprehensive care. That's why collaboration across specialties, as well as the integration of psychosocial support, school coordination, and structured transition planning, can improve patients'